CFA
ABMD

Clarfeld Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Clarfeld Financial Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2K Buy
+7
New +$2.43K ﹤0.01% 472

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Clarfeld Financial Advisors's ABMD Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Abiomed Inc (ABMD) in Q4 2018: 7 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #472 among its holdings.

529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Clarfeld Financial Advisors held 7 shares of Abiomed Inc worth $2K as of Q4 2018.
  • Abiomed Inc was a new Clarfeld Financial Advisors position in Q4 2018.
  • Abiomed Inc made up ﹤0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #472 holding.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.